Clinical Trial Update: SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating an SGLT2 inhibitor in patients with lupus nephritis and chronic kidney disease. The trial is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Lupus Nephritis

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: The University of Hong Kong | Conditions: Lupus Nephritis, Chronic Kidney Diseases | Phase 2 | Status: RECRUITING